Pathogenetic background for treatment of ascites and hepatorenal syndrome.
about
Cardiac and systemic haemodynamic complications of liver cirrhosis.Cardiovascular changes in cirrhosis: pathogenesis and clinical implications.Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.Beta-blockers in cirrhosis and refractory ascites: a retrospective cohort study and review of the literature.Immunologic, hemodynamic, and adrenal incompetence in cirrhosis: impact on renal dysfunction.Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options.Hepatic erythropoietin response in cirrhosis. A contemporary review.Role of albumin in cirrhosis: from a hospitalist's perspective.The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.Renal dysfunction in patients with chronic liver disease.Efficacy of combination therapy with natriuretic and aquaretic drugs in cirrhotic ascites patients: A randomized study.Review article: the role of the microcirculation in liver cirrhosis.Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension.Renal function and severity of bright liver. Relationship with insulin resistance, intrarenal resistive index, and glomerular filtration rate.
P2860
Q37368987-0009794E-FEE0-4B2F-B274-FAA0FEC37294Q37771146-8C11A528-02E3-4720-B9AE-083412C2468BQ38199770-DE6688F8-085B-465B-9261-586020C5DEE4Q38239061-A37A4E87-1438-4F83-881C-A579E2C7FFFCQ38383495-396B8992-51BC-4347-A86F-D2F6462EEC07Q38654403-D64C941C-1518-4B38-AFFC-7A91B2B5F865Q38751471-4B278DA6-5765-4B47-B615-271BF5085F21Q39387113-8E7554F6-BDAE-4423-829C-110419834C3DQ41666713-93F47956-BC61-40C5-90AD-3B18A5DA2E5AQ42614715-F01A49F1-70B6-43B3-B1BF-E03FCD45523BQ47280183-C3067281-7A4D-46D4-A2E4-3F9D416523A4Q47812599-B16AE81E-E69E-435F-A541-54441EBBCE4FQ48005805-9157F382-219B-4527-84A1-CC3174A74214Q51040544-87791226-72AA-4FC6-A0F6-E671938D12FF
P2860
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
@en
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
@nl
type
label
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
@en
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
@nl
prefLabel
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
@en
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
@nl
P2860
P1476
Pathogenetic background for treatment of ascites and hepatorenal syndrome.
@en
P2093
Flemming Bendtsen
Jens H Henriksen
P2860
P2888
P304
P356
10.1007/S12072-008-9100-3
P50
P577
2008-09-20T00:00:00Z